These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9375965)

  • 1. Nitric oxide effects on cell growth: GMP-dependent stimulation of the AP-1 transcription complex and cyclic GMP-independent slowing of cell cycling.
    Sciorati C; Nisticò G; Meldolesi J; Clementi E
    Br J Pharmacol; 1997 Oct; 122(4):687-97. PubMed ID: 9375965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factor-induced Ca2+ responses are differentially modulated by nitric oxide via activation of a cyclic GMP-dependent pathway.
    Clementi E; Sciorati C; Nisticò G
    Mol Pharmacol; 1995 Dec; 48(6):1068-77. PubMed ID: 8848007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone attenuation of epidermal growth factor-induced mitogenesis.
    Wiepz GJ; Houtman JC; Cha D; Bertics PJ
    J Cell Physiol; 1997 Oct; 173(1):44-53. PubMed ID: 9326448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide regulates oestrogen-activated signalling pathways at multiple levels through cyclic GMP-dependent recruitment of insulin receptor substrate 1.
    Falcone S; Mauro L; de Rose G; Paolucci C; Sciorati C; Ando S; Clementi E
    Biochem J; 2002 Aug; 366(Pt 1):165-73. PubMed ID: 11978177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: the role of cyclic GMP and tyrosine phosphatase inhibition.
    Callsen D; Pfeilschifter J; Brüne B
    J Immunol; 1998 Nov; 161(9):4852-8. PubMed ID: 9794418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
    J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures.
    Nisoli E; Clementi E; Tonello C; Sciorati C; Briscini L; Carruba MO
    Br J Pharmacol; 1998 Oct; 125(4):888-94. PubMed ID: 9831929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
    Li J; Ma C; Huang Y; Luo J; Huang C
    Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of atrial natriuretic peptide and sodium nitroprusside on epidermal growth factor-stimulated wound repair in rabbit corneal epithelial cells.
    Zhang Y; Islam M; Akhtar RA
    Curr Eye Res; 2000 Sep; 21(3):748-56. PubMed ID: 11120563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
    Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS
    J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide and cell proliferation.
    Villalobo A
    FEBS J; 2006 Jun; 273(11):2329-44. PubMed ID: 16704409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endosomal signalling of epidermal growth factor receptors contributes to EGF-stimulated cell cycle progression in primary hepatocytes.
    Luo Y; Cheng Z; Dixon CJ; Hall JF; Taylor E; Boarder MR
    Eur J Pharmacol; 2011 Mar; 654(2):173-80. PubMed ID: 21172338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
    Gordge MP; Hothersall JS; Noronha-Dutra AA
    Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
    Wang Z; Wang M; Carr BI
    J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
    Díaz-Troya S; Najib S; Sánchez-Margalet V
    Regul Pept; 2005 Feb; 125(1-3):41-6. PubMed ID: 15582712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism.
    Núñez L; Vaquero M; Gómez R; Caballero R; Mateos-Cáceres P; Macaya C; Iriepa I; Gálvez E; López-Farré A; Tamargo J; Delpón E
    Cardiovasc Res; 2006 Oct; 72(1):80-9. PubMed ID: 16876149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation.
    Léotoing L; Manin M; Monté D; Baron S; Communal Y; Lours C; Veyssière G; Morel L; Beaudoin C
    J Mol Endocrinol; 2007 Aug; 39(2):151-62. PubMed ID: 17693613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of epidermal growth factor receptor in ethanol-mediated inhibition of activator protein-1 transactivation.
    Ma C; Bower KA; Lin H; Chen G; Huang C; Shi X; Luo J
    Biochem Pharmacol; 2005 Jun; 69(12):1785-94. PubMed ID: 15878157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic GMP-dependent and cyclic GMP-independent actions of nitric oxide on the renal afferent arteriole.
    Trottier G; Triggle CR; O'Neill SK; Loutzenhiser R
    Br J Pharmacol; 1998 Oct; 125(3):563-9. PubMed ID: 9806341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.